Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2025 Earnings Presentation / 2025-07-31 IR Room
  • [Research] Hanwha Ocean (042660) – Eugene | High-Price Order Mix · Merchant Margin Continuity · Special Ship Pipeline / 2026-07-28 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q1 2024 Earnings Presentation / 2024-04-29 IR Room
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Memory ASP · Supply Tightness · Pricing Power / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | ADR Listing · HBM Pricing · Valuation Re-rating / 2026-06-30 Research
  • [Research] LigaChem Biosciences (141080) – Eugene Investment & Securities | Pipeline Clinical Progression · Licensing Revenue · Earnings Turnaround / 2025-02-17 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | Plant 5 Operation · Fixed-Cost Operating Leverage · Plant 6 Expansion / 2026-05-19 Research

[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04

Posted on March 4, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Mirae Asset Securities

Analyst : Younggun Kim

Investment Rating : BUY (Maintained)

Target Price : 1,540,000 KRW (Maintained)

Core Momentum : Resilient memory pricing and a widening gap between limited capacity expansion and demand growth indicate that underlying fundamentals remain intact, while the geopolitically driven share-price correction has created significant valuation appeal.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price / Investment Rating: 1,540,000 KRW / BUY (Maintain)
  • Current Price (as of 3/4/26): 849,000 KRW (Upside potential: 81.4%)
  • Market Capitalization: 605,084 billion KRW (KOSPI 5,093.54pt)
  • Key Financial Metrics (2023 / 2024 / 2025F / 2026F / 2027F):
    • Revenue: 32,766 billion KRW / 66,193 billion KRW / 97,147 billion KRW / 274,244 billion KRW / 371,734 billion KRW
    • Operating Profit: -7,730 billion KRW / 23,467 billion KRW / 47,244 billion KRW / 185,296 billion KRW / 255,770 billion KRW
    • Operating Profit Margin: -23.6% / 35.5% / 48.6% / 67.6% / 68.8%
    • Net Income: -9,112 billion KRW / 19,789 billion KRW / 43,753 billion KRW / 155,742 billion KRW / 217,268 billion KRW
    • EPS: -12,517 KRW / 27,182 KRW / 60,100 KRW / 213,931 KRW / 298,444 KRW
    • ROE: -15.6% / 31.1% / 46.1% / 80.9% / 57.7%
    • P/E: NA / 6.4x / 10.8x / 4.0x / 2.8x
    • P/B: 1.8x / 1.7x / 4.0x / 2.3x / 1.3x

🚀 2. [Market Opportunities & Business Outlook]

  • Distorted Correction from Panic Selling: Following U.S. airstrikes in Iran on February 28, the share price shed 20.0% within just three sessions—outpacing broader market losses—in what constitutes a classic panic-driven sell-off completely detached from fundamental deterioration.
  • Preserved Earnings Visibility: Full-year profit trajectories remain locked in at 30.4 trillion KRW for 1Q26F and 185 trillion KRW for FY26. Because earnings projections were left untouched while prices plunged, valuation multiples compressed severely to 1.96x forward P/B and 3.7x P/E.
  • Pricing Defense and Demand Buffers: With the vast majority of demand tied to Big Tech—situated safely away from immediate conflict theaters—and consumer IT hardware already reflecting prior shipment reductions, abrupt demand destruction will remain muted despite wartime inflation pressures.
  • Widening Structural Deficits: Projected 2026 wafer capacity expansions (DRAM +8.5%, NAND -1.0%) lag far behind estimated demand bit growth (DRAM +24.8%, NAND +14.8%), signaling an extended period of tight supply dynamics.

📝 Editor’s Comment (Perspective)

The analyst evaluates that the fundamental impact of geopolitical risks is expected to be limited, and that the steep downward price movement sparked by these tensions represents a textbook panic sell. With earnings targets intact, severely discounted multiples, and persistent supply deficits, initiating aggressive accumulation is deemed highly appropriate.

To determine whether this investment thesis is unfolding as projected, key items to monitor include the realization of Q1 operating profit estimates (30.4 trillion KRW), the preservation of stable memory spot and contract prices, and the broader extension of tight supply conditions. These developments can be tracked through upcoming quarterly and annual earnings releases, official corporate IR materials, and regulatory disclosures via DART/KRX.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03
Next Post: [Research] SK hynix (000660 / SKHY) – Daishin | Memory ASP · Earnings Upgrades · Valuation Appeal / 2026-03-16

Related Posts

  • [Research] SK hynix (000660 / SKHY) – Daishin | HBM4 · Memory Supply Shortage · Shareholder Returns / 2026-01-02 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Operating Leverage · Shareholder Returns / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | Agentic AI · High-Value Memory · Pricing Momentum / 2026-04-24 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Hypothetical SDC Stake Monetization · North American ESS Acceleration · Valuation Appeal / 2026-01-19 Research
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC ASP Rise · FCBGA Margin Expansion · Earnings Upward Revision / 2026-07-31 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | MLCC Price Hikes · Server Product Mix · Target Price Revision / 2026-07-31 Research
  • [Research] Samsung Biologics (207940) – Kiwoom Securities | Plant 6 Groundbreaking Visibility · Labor Negotiation · Rockville Revenue Recognition / 2026-04-02 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Supply Constraints · Memory Pricing · Earnings Growth / 2026-05-21 Research
  • [Research] LIG D&A (079550) – Eugene Investment & Securities | Global Demand Spillover · CapEx Expansion · Long-term Compounding / 2026-08-07 Research
  • [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Readout · ABL111 Phase 3 · Grabody B Expansion / 2026-04-07 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2026 Earnings Presentation / 2026-07-30 IR Room
  • [Research] Celltrion (068270) – DS Investment & Securities | 2nd-Gen Biosimilar Penetration · COGS Ratio Stabilization · Global Capacity Expansion / 2026-05-07 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | ESS & BBU Growth · Profit Turnaround · Core Earnings Sustainability / 2026-07-31 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | CAPEX Surge · Foreign Inflows · Target Price Upgrade / 2026-07-16 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme